Unlocking Insights: Navigating COVID-19 Challenges and Emulating Future Pandemic Resilience Strategies with Strengthening Natural Immunity

{ 'indexed': {'date-parts': [[2024, 7, 18]], 'date-time': '2024-07-18T02:14:45Z', 'timestamp': 1721268885843}, 'reference-count': 241, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2024, 7, 1]], 'date-time': '2024-07-01T00:00:00Z', 'timestamp': 1719792000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2024, 7, 1]], 'date-time': '2024-07-01T00:00:00Z', 'timestamp': 1719792000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/legal/tdmrep-license'}, { 'start': { 'date-parts': [[2024, 7, 15]], 'date-time': '2024-07-15T00:00:00Z', 'timestamp': 1721001600000}, 'content-version': 'vor', 'delay-in-days': 14, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'content-domain': { 'domain': ['cell.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2024, 7]]}, 'DOI': '10.1016/j.heliyon.2024.e34691', 'type': 'journal-article', 'created': {'date-parts': [[2024, 7, 18]], 'date-time': '2024-07-18T01:35:04Z', 'timestamp': 1721266504000}, 'page': 'e34691', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Unlocking Insights: Navigating COVID-19 Challenges and Emulating Future Pandemic Resilience ' 'Strategies with Strengthening Natural Immunity', 'prefix': '10.1016', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-1096-8595', 'authenticated-orcid': False, 'given': 'Sunil J.', 'family': 'Wimalawansa', 'sequence': 'first', 'affiliation': []}], 'member': '78', 'reference': [ { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib1', 'doi-asserted-by': 'crossref', 'first-page': '110', 'DOI': '10.1038/s41541-023-00708-9', 'article-title': 'Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) ' 'increases neutralization of matched Omicron variants', 'volume': '8', 'author': 'Springer', 'year': '2023', 'journal-title': 'NPJ Vaccines'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib2', 'doi-asserted-by': 'crossref', 'first-page': '183', 'DOI': '10.1016/S1473-3099(21)00648-4', 'article-title': 'Community transmission and viral load kinetics of the SARS-CoV-2 delta ' '(B.1.617.2) variant in vaccinated and unvaccinated individuals in the ' 'UK: a prospective, longitudinal, cohort study', 'volume': '22', 'author': 'Singanayagam', 'year': '2022', 'journal-title': 'Lancet Infect Dis'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib3', 'doi-asserted-by': 'crossref', 'first-page': '305', 'DOI': '10.1177/0194599820982633', 'article-title': 'COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and ' 'Asymptomatic Transmission', 'volume': '164', 'author': 'Bleier', 'year': '2021', 'journal-title': 'Otolaryngology--head and neck surgery : official journal of American ' 'Academy of Otolaryngology-Head and Neck Surgery'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib4', 'article-title': 'SARS-CoV-2 Omicron variant: epidemiological features, biological ' 'characteristics, and clinical significance', 'volume': '13', 'author': 'Guo', 'year': '2022', 'journal-title': 'Front Immunol'}, { 'issue': '7', 'key': '10.1016/j.heliyon.2024.e34691_bib5', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/nu12072097', 'article-title': 'Immunologic effects of vitamin D on human health and sisease', 'volume': '12', 'author': 'Charoenngam', 'year': '2020', 'journal-title': 'Nutrients'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib6', 'doi-asserted-by': 'crossref', 'first-page': '10', 'DOI': '10.1016/j.molimm.2022.11.020', 'article-title': 'Immune evasion of severe acute respiratory syndrome coronavirus-2 ' '(SARS-CoV-2); molecular approaches', 'volume': '156', 'author': 'Ahmadi', 'year': '2023', 'journal-title': 'Mol Immunol'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib7', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.1016/j.mib.2014.05.005', 'article-title': 'To sense or not to sense viral RNA--essentials of coronavirus innate ' 'immune evasion', 'volume': '20', 'author': 'Kindler', 'year': '2014', 'journal-title': 'Curr Opin Microbiol'}, { 'issue': '41', 'key': '10.1016/j.heliyon.2024.e34691_bib8', 'doi-asserted-by': 'crossref', 'first-page': '29821', 'DOI': '10.1074/jbc.M705495200', 'article-title': '1,25-dihydroxyvitamin D3 suppresses renin gene transcription by ' 'blocking the activity of the cyclic AMP response element in the renin ' 'gene promoter', 'volume': '282', 'author': 'Yuan', 'year': '2007', 'journal-title': 'J Biol Chem'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib9', 'unstructured': 'FDA. Emergency use authorization for vaccines explained. FDA.gov. ' 'Accessed May 22nd, 2022. ' 'https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained'}, { 'issue': '40', 'key': '10.1016/j.heliyon.2024.e34691_bib10', 'doi-asserted-by': 'crossref', 'first-page': '5798', 'DOI': '10.1016/j.vaccine.2022.08.036', 'article-title': 'Serious adverse events of special interest following mRNA COVID-19 ' 'vaccination in randomized trials in adults', 'volume': '40', 'author': 'Fraiman', 'year': '2022', 'journal-title': 'Vaccine'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib11', 'doi-asserted-by': 'crossref', 'first-page': '411', 'DOI': '10.1186/s12879-021-06104-9', 'article-title': 'Evaluation of the effectiveness and safety of adding ivermectin to ' 'treatment in severe COVID-19 patients', 'volume': '21', 'author': 'Okumus', 'year': '2021', 'journal-title': 'BMC Infect Dis'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib12', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.53294/ijfstr.2024.6.2.0031', 'article-title': 'Decoding the paradox: Understanding elevated hospitalization and ' 'reduced mortality in SARS-CoV-2 variants', 'volume': '6', 'author': 'Wimalawansa', 'year': '2024', 'journal-title': 'Int J Frontiers in Sci and Technol Res'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib13', 'doi-asserted-by': 'crossref', 'first-page': '1007', 'DOI': '10.1016/j.clinthera.2021.04.007', 'article-title': 'Effects of ivermectin in patients With COVID-19: A multicenter, ' 'double-blind, randomized, controlled clinical trial', 'volume': '43', 'author': 'Shahbaznejad', 'year': '2021', 'journal-title': 'Clin Ther'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib14', 'article-title': 'The PRISMA 2020 statement: an updated guideline for reporting ' 'systematic reviews', 'volume': '372', 'author': 'Page', 'year': '2021', 'journal-title': 'BMJ'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib15', 'doi-asserted-by': 'crossref', 'first-page': '104', 'DOI': '10.1038/s41541-021-00369-6', 'article-title': 'Distinguishing features of current COVID-19 vaccines: knowns and ' 'unknowns of antigen presentation and modes of action', 'volume': '6', 'author': 'Heinz', 'year': '2021', 'journal-title': 'NPJ Vaccines'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib16', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.addr.2021.114000', 'article-title': 'Messenger RNA-based vaccines: Past, present, and future directions in ' 'the context of the COVID-19 pandemic', 'volume': '179', 'author': 'Jain', 'year': '2021', 'journal-title': 'Adv Drug Deliv Rev'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib17', 'doi-asserted-by': 'crossref', 'DOI': '10.1002/rmv.2183', 'article-title': 'Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based ' 'vaccine candidates: State of the art and future prospects', 'volume': '31', 'author': 'Arashkia', 'year': '2021', 'journal-title': 'Rev Med Virol'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib18', 'doi-asserted-by': 'crossref', 'first-page': '1446', 'DOI': '10.7150/ijbs.59233', 'article-title': 'mRNA vaccines for COVID-19: what, why and how', 'volume': '17', 'author': 'Park', 'year': '2021', 'journal-title': 'International journal of biological sciences'}, { 'issue': '11', 'key': '10.1016/j.heliyon.2024.e34691_bib19', 'doi-asserted-by': 'crossref', 'first-page': '685', 'DOI': '10.1038/s41579-021-00630-8', 'article-title': 'Structural biology of SARS-CoV-2 and implications for therapeutic ' 'development', 'volume': '19', 'author': 'Yang', 'year': '2021', 'journal-title': 'Nat Rev Microbiol'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib20', 'article-title': 'Recent Advances in the Molecular Design and Delivery Technology of mRNA ' 'for Vaccination Against Infectious Diseases', 'volume': '13', 'author': 'Yang', 'year': '2022', 'journal-title': 'Front Immunol'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib21', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/ijms24021404', 'article-title': 'Concern about the effectiveness of mRNA vaccination technology and Its ' 'long-term safety: potential interference on miRNA machinery', 'volume': '24', 'author': 'Stati', 'year': '2023', 'journal-title': 'Int J Mol Sci.'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib22', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fimmu.2020.575074', 'article-title': 'Measurement of Cellular Immune Response to Viral Infection and ' 'Vaccination', 'volume': '11', 'author': 'Bouwman', 'year': '2020', 'journal-title': 'Front Immunol'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib23', 'doi-asserted-by': 'crossref', 'first-page': '1400', 'DOI': '10.3389/fimmu.2019.01400', 'article-title': 'Recalling the Future: Immunological Memory Toward Unpredictable ' 'Influenza Viruses', 'volume': '10', 'author': 'Auladell', 'year': '2019', 'journal-title': 'Front Immunol'}, { 'issue': '7', 'key': '10.1016/j.heliyon.2024.e34691_bib24', 'doi-asserted-by': 'crossref', 'first-page': '542', 'DOI': '10.1016/j.molmed.2022.04.007', 'article-title': 'Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis', 'volume': '28', 'author': 'Trougakos', 'year': '2022', 'journal-title': 'Trends Mol Med'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib25', 'doi-asserted-by': 'crossref', 'first-page': '94', 'DOI': '10.1038/s41392-022-00950-y', 'article-title': 'Advances in COVID-19 mRNA vaccine development', 'volume': '7', 'author': 'Fang', 'year': '2022', 'journal-title': 'Signal Transduct Target Ther'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib26', 'first-page': '1', 'article-title': 'What modelling and reproduction numbers are useful in predicting ' 'COVID-19 spread?', 'volume': '3', 'author': 'Wimalawansa', 'year': '2020', 'journal-title': 'Can J Biomed Res & Tech'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib27', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fmicb.2022.908525', 'article-title': 'Influenza A, Influenza B, and SARS-CoV-2 similarities and differences - ' 'A focus on diagnosis', 'volume': '13', 'author': 'Havasi', 'year': '2022', 'journal-title': 'Front Microbiol'}, { 'issue': '11', 'key': '10.1016/j.heliyon.2024.e34691_bib28', 'doi-asserted-by': 'crossref', 'first-page': '1319', 'DOI': '10.4161/rna.22269', 'article-title': 'Developing mRNA-vaccine technologies', 'volume': '9', 'author': 'Schlake', 'year': '2012', 'journal-title': 'RNA Biol'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib29', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/biomedicines11020451', 'article-title': 'Immune response and molecular mechanisms of cardiovascular adverse ' 'effects of Spike Proteins from SARS-CoV-2 and mRNA vaccines', 'volume': '11', 'author': 'Bellavite', 'year': '2023', 'journal-title': 'Biomedicines'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib30', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.fct.2022.113008', 'article-title': 'Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of ' 'G-quadruplexes, exosomes, and MicroRNAs', 'volume': '164', 'author': 'Seneff', 'year': '2022', 'journal-title': 'Food and chemical toxicology : an international journal published for ' 'the British Industrial Biological Research Association'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib31', 'doi-asserted-by': 'crossref', 'first-page': '235', 'DOI': '10.4155/tde-2020-0129', 'article-title': 'An overview of vaccine development for COVID-19', 'volume': '12', 'author': 'Shahcheraghi', 'year': '2021', 'journal-title': 'Ther Deliv'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib32', 'article-title': 'Immune responses induced by mRNA vaccination in mice, monkeys and ' 'humans', 'volume': '9', 'author': 'Cagigi', 'year': '2021', 'journal-title': 'Vaccines (Basel)'}, { 'issue': '15', 'key': '10.1016/j.heliyon.2024.e34691_bib33', 'doi-asserted-by': 'crossref', 'first-page': '1355', 'DOI': '10.1056/NEJMoa2110362', 'article-title': 'Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care ' 'Settings', 'volume': '385', 'author': 'Thompson', 'year': '2021', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib34', 'unstructured': 'Office-GAO-21-319 GA. Operation Warp Speed: Accelerated COVID-19 vaccine ' 'development status and efforts to address manufacturing challenges. ' 'GAO.'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib35', 'article-title': 'Why does COVID-19 continue to spread despite mass vaccination?', 'volume': '10', 'author': 'Zhang', 'year': '2022', 'journal-title': 'Front Public Health'}, { 'issue': '39', 'key': '10.1016/j.heliyon.2024.e34691_bib36', 'doi-asserted-by': 'crossref', 'first-page': '5651', 'DOI': '10.1016/j.vaccine.2022.08.040', 'article-title': 'The impact of a vaccine mandate and the COVID-19 pandemic on influenza ' 'vaccination uptake in Western Australian health care students', 'volume': '40', 'author': 'Willis', 'year': '2022', 'journal-title': 'Vaccine'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib37', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.jvacx.2022.100213', 'article-title': 'Trust is the common denominator for COVID-19 vaccine acceptance: A ' 'literature review', 'volume': '12', 'author': 'Adhikari', 'year': '2022', 'journal-title': 'Vaccine X'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib38', 'doi-asserted-by': 'crossref', 'DOI': '10.24926/iip.v12i4.4294', 'article-title': 'An overview of COVID-19 vaccine safety and post-marketing surveillance ' 'systems', 'volume': '12', 'author': 'Younus', 'year': '2021', 'journal-title': 'Innov Pharm'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib39', 'doi-asserted-by': 'crossref', 'first-page': '831', 'DOI': '10.1007/s40258-023-00816-6', 'article-title': 'Drug repurposing of generic drugs: Challenges and the potential role ' 'for government', 'volume': '21', 'author': 'van der Pol', 'year': '2023', 'journal-title': 'Applied health economics and health policy'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib40', 'doi-asserted-by': 'crossref', 'first-page': '68', 'DOI': '10.1186/s12929-022-00852-9', 'article-title': 'A critical overview of current progress for COVID-19: development of ' 'vaccines, antiviral drugs, and therapeutic antibodies', 'volume': '29', 'author': 'Kumari', 'year': '2022', 'journal-title': 'J Biomed Sci'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib41', 'unstructured': 'Union E. the European Parliament and of the Council on the Community ' 'code relating to medicinal products for human use: Commission Directive ' '2003/63/EC. European Union. Accessed November 12, 2022. ' 'https://eur-lex.europa.eu/legal-content/en/ALL/?uri=CELEX%3A32003L0063'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib42', 'doi-asserted-by': 'crossref', 'first-page': '2768', 'DOI': '10.3389/fimmu.2019.02768', 'article-title': 'Plasma Cells, the Next Generation: Beyond Antibody Secretion', 'volume': '10', 'author': 'Pioli', 'year': '2019', 'journal-title': 'Front Immunol'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib43', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ebiom.2022.103962', 'article-title': 'Reporting and data sharing level for COVID-19 vaccine trials: A ' 'cross-sectional study', 'volume': '78', 'author': 'Duan', 'year': '2022', 'journal-title': 'EBioMedicine'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib44', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fpubh.2022.999354', 'article-title': 'Adverse events following immunization of COVID-19 vaccine among ' 'children aged 6-11 years', 'volume': '10', 'author': 'Puspitarani', 'year': '2022', 'journal-title': 'Front Public Health'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib45', 'doi-asserted-by': 'crossref', 'first-page': '82', 'DOI': '10.1186/s12929-022-00853-8', 'article-title': 'COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, ' 'boosters, adverse effects, and immune correlates of protection', 'volume': '29', 'author': 'Chi', 'year': '2022', 'journal-title': 'J Biomed Sci'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib46', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pmed.1004245', 'article-title': 'Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine ' 'booster and after COVID-19 in those with and without prior SARS-CoV-2 ' 'infection: A self-controlled case series analysis in England', 'volume': '20', 'author': 'Stowe', 'year': '2023', 'journal-title': 'PLoS Med'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib47', 'doi-asserted-by': 'crossref', 'first-page': '110', 'DOI': '10.2188/jea.JE20220265', 'article-title': 'Adverse reactions and attitudes toward the BNT162b2 COVID-19 vaccine in ' 'children 5 to 11 years of age in Japan', 'volume': '33', 'author': 'Matsumoto', 'year': '2023', 'journal-title': 'J Epidemiol'}, { 'issue': '10', 'key': '10.1016/j.heliyon.2024.e34691_bib48', 'article-title': 'An update on complications associated with SARS-CoV-2 infection and ' 'COVID-19 vaccination', 'volume': '10', 'author': 'Chowdhury', 'year': '2022', 'journal-title': 'Vaccines (Basel)'}, { 'issue': '12', 'key': '10.1016/j.heliyon.2024.e34691_bib49', 'doi-asserted-by': 'crossref', 'first-page': '1725', 'DOI': '10.1016/j.jsps.2022.10.001', 'article-title': 'Vaccine adverse event reporting system (VAERS): Evaluation of 31 years ' "of reports and pandemics' impact", 'volume': '30', 'author': 'Almadani', 'year': '2022', 'journal-title': 'Saudi Pharm J'}, { 'issue': '18', 'key': '10.1016/j.heliyon.2024.e34691_bib50', 'doi-asserted-by': 'crossref', 'first-page': '2879', 'DOI': '10.1016/j.vaccine.2023.03.054', 'article-title': 'Real-life safety profile of mRNA vaccines for COVID-19: An analysis of ' 'VAERS database', 'volume': '41', 'author': 'Santi', 'year': '2023', 'journal-title': 'Vaccine'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib51', 'article-title': 'Real-world safety of COVID-19 mRNA vaccines: A systematic review and ' 'meta-snalysis', 'volume': '11', 'author': 'Xu', 'year': '2023', 'journal-title': 'Vaccines (Basel)'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib52', 'doi-asserted-by': 'crossref', 'first-page': '257', 'DOI': '10.1038/s41419-024-06642-5', 'article-title': 'Research progress of post-acute sequelae after SARS-CoV-2 infection', 'volume': '15', 'author': 'Jiao', 'year': '2024', 'journal-title': 'Cell Death Dis.'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib53', 'doi-asserted-by': 'crossref', 'first-page': '1716', 'DOI': '10.1038/s41467-024-45953-1', 'article-title': 'Persistence in risk and effect of COVID-19 vaccination on long-term ' 'health consequences after SARS-CoV-2 infection', 'volume': '15', 'author': 'Lam', 'year': '2024', 'journal-title': 'Nat Commun'}, { 'issue': '11', 'key': '10.1016/j.heliyon.2024.e34691_bib54', 'doi-asserted-by': 'crossref', 'first-page': '1874', 'DOI': '10.1016/j.hrthm.2022.07.019', 'article-title': 'Genetic basis of sudden death after COVID-19 vaccination in Thailand', 'volume': '19', 'author': 'Ittiwut', 'year': '2022', 'journal-title': 'Heart Rhythm'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib55', 'doi-asserted-by': 'crossref', 'DOI': '10.1590/s1678-9946202365050', 'article-title': 'COVID-19-related multisystem inflammatory syndrome in adult: the first ' 'death in Brazil', 'volume': '65', 'author': 'Salomao', 'year': '2023', 'journal-title': 'Rev Inst Med Trop Sao Paulo.'}, { 'issue': '9', 'key': '10.1016/j.heliyon.2024.e34691_bib56', 'doi-asserted-by': 'crossref', 'DOI': '10.1161/JAHA.121.024393', 'article-title': 'Comparison of multisystem inflammatory syndrome in children-related ' 'myocarditis, classic viral myocarditis, and COVID-19 vaccine-related ' 'myocarditis in children', 'volume': '11', 'author': 'Patel', 'year': '2022', 'journal-title': 'J Am Heart Assoc'}, { 'issue': '7', 'key': '10.1016/j.heliyon.2024.e34691_bib57', 'doi-asserted-by': 'crossref', 'first-page': '1561', 'DOI': '10.1111/jog.15285', 'article-title': 'The vaccination status and adverse effects of COVID-19 vaccine among ' 'pregnant women in Japan in 2021', 'volume': '48', 'author': 'Komine-Aizawa', 'year': '2022', 'journal-title': 'J Obstet Gynaecol Res'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib58', 'doi-asserted-by': 'crossref', 'first-page': '436', 'DOI': '10.1161/CIRCULATIONAHA.123.064772', 'article-title': 'Cardiovascular assessment up to one year after COVID-19 ' 'vaccine-associated myocarditis', 'volume': '148', 'author': 'Yu', 'year': '2023', 'journal-title': 'Circulation'}, { 'issue': '24', 'key': '10.1016/j.heliyon.2024.e34691_bib59', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/ijms232415480', 'article-title': 'SARS-CoV-2 Spike protein induces hemagglutination: implications for ' 'COVID-19 morbidities and therapeutics and for vaccine adverse effects', 'volume': '23', 'author': 'Boschi', 'year': '2022', 'journal-title': 'Int J Mol Sci'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib60', 'doi-asserted-by': 'crossref', 'first-page': '292', 'DOI': '10.1016/j.jaip.2022.10.010', 'article-title': 'COVID-19 severity, cardiological outcome, and Immunogenicity of mRNA ' 'vaccine on adult patients with 22q11.2 DS', 'volume': '11', 'author': 'Pulvirenti', 'year': '2023', 'journal-title': 'J Allergy Clin Immunol Pract'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib61', 'doi-asserted-by': 'crossref', 'first-page': '80', 'DOI': '10.12788/cutis.0700', 'article-title': 'Adverse Effects of the COVID-19 Vaccine in Patients With Psoriasis', 'volume': '111', 'author': 'Shin', 'year': '2023', 'journal-title': 'Cutis'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib62', 'article-title': 'COVID-19 and COVID-19 vaccine-related dermatological reactions: An ' 'interesting case series with a narrative review of the potential ' 'critical and non-critical mucocutaneous adverse effects related to ' 'virus, therapy, and the vaccination', 'volume': '10', 'author': 'Pour', 'year': '2022', 'journal-title': 'Clin Case Rep'}, { 'issue': '11', 'key': '10.1016/j.heliyon.2024.e34691_bib63', 'article-title': 'COVID-19 vaccine-associated ocular adverse effects: An overview', 'volume': '10', 'author': 'Ichhpujani', 'year': '2022', 'journal-title': 'Vaccines (Basel)'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib64', 'doi-asserted-by': 'crossref', 'first-page': '157', 'DOI': '10.1002/ana.26369', 'article-title': 'Vaccine adverse Event reporting system could miss or misinterpret ' 'neurological side effects of COVID-19 vaccinations', 'volume': '92', 'author': 'Finsterer', 'year': '2022', 'journal-title': 'Ann Neurol'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib65', 'doi-asserted-by': 'crossref', 'first-page': 'C1', 'DOI': '10.1152/ajpcell.00375.2021', 'article-title': 'Long-term complications of COVID-19', 'volume': '322', 'author': 'Desai', 'year': '2022', 'journal-title': 'Am J Physiol Cell Physiol'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib66', 'unstructured': 'FDA. COVID-19 bivalent vaccine boosters. FDA. Accessed Dec 15, 2022. ' 'https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-bivalent-vaccine-boosters'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib67', 'article-title': 'Effectiveness of the coronavirus disease 2019 (COVID-19) bivalent ' 'vaccine', 'author': 'Shrestha', 'year': '2023', 'journal-title': 'Preprint: MedRxiv'}, { 'issue': '10', 'key': '10.1016/j.heliyon.2024.e34691_bib68', 'article-title': 'Vaccine hesitancy: Contemporary issues and historical background', 'volume': '10', 'author': 'Nuwarda', 'year': '2022', 'journal-title': 'Vaccines (Basel)'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib69', 'doi-asserted-by': 'crossref', 'DOI': '10.1038/s41591-023-02219-5', 'article-title': 'Author Correction: Real-world COVID-19 vaccine effectiveness against ' 'the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population', 'author': 'Lau', 'year': '2023', 'journal-title': 'Nat Med'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib70', 'doi-asserted-by': 'crossref', 'DOI': '10.1038/s41598-022-22014-5', 'article-title': 'Conspiratorial thinking as a precursor to opposition to COVID-19 ' 'vaccination in the US: a multi-year study from 2018 to 2021', 'volume': '12', 'author': 'Romer', 'year': '2022', 'journal-title': 'Sci Rep'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib71', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijid.2024.107057', 'article-title': 'The contribution of SARS-CoV-2 to the burden of acute respiratory ' 'infections in winter season 2022/2023: Results from the DigiHero study', 'author': 'Glaser', 'year': '2024', 'journal-title': 'Int J Infect Dis'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib72', 'doi-asserted-by': 'crossref', 'first-page': '211', 'DOI': '10.4161/derm.24476', 'article-title': 'Seasonal variation in the serum 25-hydroxyvitamin D levels of young and ' 'elderly active and inactive adults in Sao Paulo, Brazil: The Sao PAulo ' 'Vitamin D Evaluation Study (SPADES)', 'volume': '5', 'author': 'Maeda', 'year': '2013', 'journal-title': 'Dermatoendocrinol'}, { 'issue': '14', 'key': '10.1016/j.heliyon.2024.e34691_bib73', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/nu14142997', 'article-title': 'Rapidly increasing serum 25(OH)D boosts the immune system, against ' 'infections-sepsis and COVID-19', 'volume': '14', 'author': 'Wimalawansa', 'year': '2022', 'journal-title': 'Nutrients'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib74', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/biomedicines11061542', 'article-title': 'Physiological basis for using vitamin D to improve health', 'volume': '11', 'author': 'Wimalawansa', 'year': '2023', 'journal-title': 'Biomedicines'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib75', 'doi-asserted-by': 'crossref', 'first-page': '688', 'DOI': '10.5946/ce.2022.146', 'article-title': 'General guideline in the endoscopy room to avoid air-borne infection ' 'during the COVID-19 pandemic', 'volume': '55', 'author': 'Chung', 'year': '2022', 'journal-title': 'Clin Endosc'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib76', 'first-page': '1', 'article-title': 'Modes of preventing secondary community spread and future epidemics of ' 'COVID-19', 'volume': '5', 'author': 'Wimalawansa', 'year': '2020', 'journal-title': 'J Immuno Biol'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib77', 'doi-asserted-by': 'crossref', 'first-page': '37', 'DOI': '10.2147/PLMI.S373617', 'article-title': 'Overcoming infections including COVID-19, by maintaining circulating ' '25(OH)D concentrations above 50 ng/mL', 'volume': '14', 'author': 'Wimalawansa', 'year': '2022', 'journal-title': 'Pathology & Lab Medicine Int.'}, { 'issue': '9', 'key': '10.1016/j.heliyon.2024.e34691_bib78', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/nu15092089', 'article-title': 'Vitamin D levels in the pre- and post-COVID-19 pandemic periods and ' 'related confinement at pediatric age', 'volume': '15', 'author': 'Mosca', 'year': '2023', 'journal-title': 'Nutrients'}, { 'issue': '12', 'key': '10.1016/j.heliyon.2024.e34691_bib79', 'first-page': '1', 'article-title': 'Molecular quantum and logic process of consciousness—Vitamin D big-data ' 'in COVID-19—A case for incorporating machine learning in medicine', 'volume': '10', 'author': 'Polonowita', 'year': '2023', 'journal-title': 'Euro J Biomedical Pharma Sci'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib80', 'doi-asserted-by': 'crossref', 'first-page': 'ofac135', 'DOI': '10.1093/ofid/ofac135', 'article-title': 'Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and ' 'Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant', 'volume': '9', 'author': 'Acharya', 'year': '2022', 'journal-title': 'Open Forum Infect Dis'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib81', 'first-page': '1349', 'article-title': 'Outbreak of SARS-CoV-2 B.1.617.2 (delta) variant infections among ' 'incarcerated persons in a federal prison—Texas, July–August 2021', 'volume': '70', 'author': 'Hagan', 'year': '2021', 'journal-title': 'The Lancet-Infectious diseases'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib82', 'doi-asserted-by': 'crossref', 'first-page': '279', 'DOI': '10.1016/j.cell.2022.12.018', 'article-title': 'Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB ' 'subvariants', 'volume': '186', 'author': 'Wang', 'year': '2023', 'journal-title': 'Cell'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib83', 'doi-asserted-by': 'crossref', 'DOI': '10.1002/rmv.2231', 'article-title': 'Neutralising antibody escape of SARS-CoV-2 spike protein: Risk ' 'assessment for antibody-based Covid-19 therapeutics and vaccines', 'volume': '31', 'author': 'Focosi', 'year': '2021', 'journal-title': 'Rev Med Virol'}, { 'issue': '7', 'key': '10.1016/j.heliyon.2024.e34691_bib84', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/jtm/taab124', 'article-title': 'The reproductive number of the Delta variant of SARS-CoV-2 is far ' 'higher compared to the ancestral SARS-CoV-2 virus', 'volume': '28', 'author': 'Liu', 'year': '2021', 'journal-title': 'J Travel Med'}, { 'issue': '7', 'key': '10.1016/j.heliyon.2024.e34691_bib85', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pone.0271305', 'article-title': 'Mutations in SARS-CoV-2 are on the increase against the acquired ' 'immunity', 'volume': '17', 'author': 'Konishi', 'year': '2022', 'journal-title': 'PLoS One'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib86', 'doi-asserted-by': 'crossref', 'DOI': '10.1128/jvi.01279-23', 'article-title': 'Protection of the receptor binding domain (RBD) dimer against ' 'SARS-CoV-2 and its variants', 'author': 'Wu', 'year': '2023', 'journal-title': 'J Virol'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib87', 'doi-asserted-by': 'crossref', 'first-page': '468', 'DOI': '10.1056/NEJMc2207519', 'article-title': 'Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, ' 'BA.4, and BA.5 Subvariants', 'volume': '387', 'author': 'Takashita', 'year': '2022', 'journal-title': 'N Engl J Med.'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib88', 'doi-asserted-by': 'crossref', 'first-page': '649', 'DOI': '10.1016/j.ijid.2021.01.018', 'article-title': 'Impact of reproduction number on the multiwave spreading dynamics of ' 'COVID-19 with temporary immunity: A mathematical model', 'volume': '104', 'author': 'Shayak', 'year': '2021', 'journal-title': 'Int J Infect Dis'}, { 'issue': '7', 'key': '10.1016/j.heliyon.2024.e34691_bib89', 'doi-asserted-by': 'crossref', 'first-page': '1491', 'DOI': '10.1038/s41591-022-01816-0', 'article-title': 'Infectious viral load in unvaccinated and vaccinated individuals ' 'infected with ancestral, Delta or Omicron SARS-CoV-2', 'volume': '28', 'author': 'Puhach', 'year': '2022', 'journal-title': 'Nat Med'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib90', 'doi-asserted-by': 'crossref', 'DOI': '10.34172/jrhs.2022.81', 'article-title': 'Ethics and effectiveness of US COVID-19 vaccine mandates and ' 'vaccination passports: A review', 'volume': '22', 'author': 'Canning', 'year': '2022', 'journal-title': 'J Res Health Sci.'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib91', 'unstructured': 'Y T. Stop calling it a pandemic of the unvaccinated. ' 'https://www.theatlantic.com/ideas/archive/2021/09/persuade-unvaccinated-protect-unvaccinated/620091/. ' 'Accessed February 4th 2023, 2023. ' 'https://www.theatlantic.com/ideas/archive/2021/09/persuade-unvaccinated-protect-unvaccinated/620091/'}, { 'issue': '16', 'key': '10.1016/j.heliyon.2024.e34691_bib92', 'doi-asserted-by': 'crossref', 'first-page': '1474', 'DOI': '10.1056/NEJMoa2109072', 'article-title': 'Covid-19 Breakthrough Infections in Vaccinated Health Care Workers', 'volume': '385', 'author': 'Bergwerk', 'year': '2021', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib93', 'article-title': 'The impact of delayed access to COVID-19 vaccines in low- and ' 'lower-middle-income countries', 'volume': '10', 'author': 'Duroseau', 'year': '2022', 'journal-title': 'Front Public Health'}, { 'issue': '9', 'key': '10.1016/j.heliyon.2024.e34691_bib94', 'article-title': 'The race for COVID-19 vaccines: accelerating innovation, fair ' 'allocation and distribution', 'volume': '10', 'author': 'Daems', 'year': '2022', 'journal-title': 'Vaccines (Basel)'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib95', 'doi-asserted-by': 'crossref', 'first-page': '553', 'DOI': '10.1016/j.healthpol.2021.03.013', 'article-title': 'COVID-19 vaccine challenges: What have we learned so far and what ' 'remains to be done?', 'volume': '125', 'author': 'Forman', 'year': '2021', 'journal-title': 'Health Policy'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib96', 'article-title': 'COVID-19 vaccine challenges in developing and developed countries', 'volume': '14', 'author': 'Yarlagadda', 'year': '2022', 'journal-title': 'Cureus'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib97', 'unstructured': 'Group-C19.com. Vitamin D for COVID-19: real-time analysis of all 300 ' 'studies: https://c19early.org/d. Accessed January 25, 2023, ' 'https://c19vitamind.com/'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib98', 'unstructured': 'Annonymos. Vaccine monopolies make cost of vaccinating the world against ' 'COVID at least 5 times more expensive than it could be. Oxfam. 2023 ' 'March 10. ' 'https://www.oxfam.org/en/press-releases/vaccine-monopolies-make-cost-vaccinating-world-against-covid-least-5-times-more'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib99', 'article-title': 'E E-P. It will be hard to find a farmer left’: Sri Lanka reels from ' 'rash fertiliser ban', 'year': '2023', 'journal-title': 'Guardian'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib100', 'unstructured': 'Athas I LC, Mogul R, Gonzalez-Roman D. Sri Lanka is ‘bankrupt,’ Prime ' 'Minister says. CNN, Sri Lanka. 2023, May 23. ' 'https://www.cnn.com/2022/07/05/asia/sri-lanka-bankrupt-fuel-crisis-intl-hnk/index.html'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib101', 'doi-asserted-by': 'crossref', 'DOI': '10.1002/rmv.2381', 'article-title': 'Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications ' 'for immune escape and transmission', 'volume': '32', 'author': 'Shrestha', 'year': '2022', 'journal-title': 'Rev Med Virol'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib102', 'doi-asserted-by': 'crossref', 'first-page': '622', 'DOI': '10.1057/s41271-021-00318-6', 'article-title': 'The disinformation playbook: how industry manipulates the ' 'science-policy process-and how to restore scientific integrity', 'volume': '42', 'author': 'Reed', 'year': '2021', 'journal-title': 'J Public Health Policy'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib103', 'unstructured': 'Grant WB. Vitamin D acceptance delayed by big pharma following the ' 'Disinformation Playbook. Accessed March 22nd, 2022, ' 'http://orthomolecular.org/resources/omns/v14n22.shtml'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib104', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.socscimed.2022.114800', 'article-title': 'The path towards herd immunity: Predicting COVID-19 vaccination uptake ' 'through results from a stated choice study across six continents', 'volume': '298', 'author': 'Hess', 'year': '2022', 'journal-title': 'Soc Sci Med'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib105', 'unstructured': 'Spencer S. Widespread claims misrepresent effectiveness of COVID-19 ' 'vaccines. FactCheck.org. Accessed NOv 10, 2022.'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib106', 'unstructured': 'FDA. Coronavirus (COVID-19) update: FDA authorizes Moderna, ' 'Pfizer-BioNTech bivalent COVID-19 vaccines for use as a booster dose. ' 'FDA. January 5th, 2023. ' 'https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-pfizer-biontech-bivalent-covid-19-vaccines-use'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib107', 'doi-asserted-by': 'crossref', 'first-page': '60', 'DOI': '10.18773/austprescr.2023.020', 'article-title': 'COVID-19 vaccines in 2023', 'volume': '46', 'author': 'Sharma', 'year': '2023', 'journal-title': 'Aust Prescr'}, { 'issue': '14', 'key': '10.1016/j.heliyon.2024.e34691_bib108', 'doi-asserted-by': 'crossref', 'first-page': '1279', 'DOI': '10.1056/NEJMoa2208343', 'article-title': 'A bivalent Omicron-containing booster vaccine against Covid-19', 'volume': '387', 'author': 'Chalkias', 'year': '2022', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib109', 'article-title': 'Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged ' 'at least 75 years during the spring-summer (monovalent vaccine) and ' 'autumn-winter (bivalent vaccine) booster campaigns: a prospective test ' 'negative case-control study, United Kingdom', 'author': 'Chatzilena', 'year': '2022', 'journal-title': 'Euro surveillance : bulletin Europeen sur les maladies transmissibles = ' 'European communicable disease bulletin'}, { 'issue': '7', 'key': '10.1016/j.heliyon.2024.e34691_bib110', 'doi-asserted-by': 'crossref', 'first-page': '2969', 'DOI': '10.1002/jmv.27697', 'article-title': 'Current evidence on efficacy of COVID-19 booster dose vaccination ' 'against the Omicron variant: A systematic review', 'volume': '94', 'author': 'Chenchula', 'year': '2022', 'journal-title': 'J Med Virol.'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib111', 'doi-asserted-by': 'crossref', 'first-page': 'e177', 'DOI': '10.1016/j.jinf.2022.10.007', 'article-title': 'No correlation of neutralizing antibody titers against the Omicron ' 'variant after a booster dose of COVID-19 vaccines with subsequent ' 'breakthrough Omicron infections among healthcare workers', 'volume': '85', 'author': 'Lee', 'year': '2022', 'journal-title': 'J Infect'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib112', 'doi-asserted-by': 'crossref', 'first-page': 'e28', 'DOI': '10.4081/jphr.2013.e28', 'article-title': 'Technology and the future of healthcare', 'volume': '2', 'author': 'Thimbleby', 'year': '2013', 'journal-title': 'J Public Health Res'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib113', 'article-title': 'Impact of Withholding Cost-Effective Early Treatments, Such as Vitamin ' 'D, on COVID-19: An Analysis Using an Innovative Logical Paradigm', 'author': 'Polonowita', 'year': '2023', 'journal-title': 'Wold J Adanced Pharma Life Sci.'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib114', 'doi-asserted-by': 'crossref', 'first-page': '365', 'DOI': '10.4103/ijd.IJD_421_20', 'article-title': 'Artificial intelligence: How is it changing medical sciences and its ' 'future?', 'volume': '65', 'author': 'Basu', 'year': '2020', 'journal-title': 'Indian J Dermatol'}, { 'issue': '10', 'key': '10.1016/j.heliyon.2024.e34691_bib115', 'article-title': 'Recent advancements in emerging technologies for healthcare management ' 'systems: A survey', 'volume': '10', 'author': 'Junaid', 'year': '2022', 'journal-title': 'Healthcare (Basel)'}, { 'issue': '9', 'key': '10.1016/j.heliyon.2024.e34691_bib116', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pone.0239252', 'article-title': 'SARS-CoV-2 positivity rates associated with circulating ' '25-hydroxyvitamin D levels', 'volume': '15', 'author': 'Kaufman', 'year': '2020', 'journal-title': 'PLoS One'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib117', 'doi-asserted-by': 'crossref', 'first-page': '451', 'DOI': '10.1093/pubmed/fdaa095', 'article-title': 'Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic ' 'populations is not explained by cardiometabolic, socioeconomic or ' 'behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases ' 'from the UK Biobank', 'volume': '42', 'author': 'Raisi-Estabragh', 'year': '2020', 'journal-title': 'Journal of public health'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib118', 'doi-asserted-by': 'crossref', 'first-page': '545', 'DOI': '10.1007/s00394-020-02372-4', 'article-title': 'Vitamin D and COVID-19 infection and mortality in UK Biobank', 'volume': '60', 'author': 'Hastie', 'year': '2021', 'journal-title': 'Eur J Nutr'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib119', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.virusres.2020.198235', 'article-title': 'Putative roles of vitamin D in modulating immune response and ' 'immunopathology associated with COVID-19', 'volume': '292', 'author': 'Kumar', 'year': '2021', 'journal-title': 'Virus Res'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib120', 'unstructured': 'Wimalawansa SJ, Polonowita, A. Boosting immunity with vitamin D for ' 'preventing complications and deaths from COVID-19. National Science ' 'Foundation, Sri Lanka.; 2021:171-198.'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib121', 'doi-asserted-by': 'crossref', 'first-page': '423', 'DOI': '10.1016/j.arcmed.2022.04.003', 'article-title': 'Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in ' 'Frontline Healthcare Workers. A Randomized Clinical Trial', 'volume': '53', 'author': 'Villasis-Keever', 'year': '2022', 'journal-title': 'Archives of medical research'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib122', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.jsbmb.2020.105751', 'article-title': 'Effect of calcifediol treatment and best available therapy versus best ' 'available therapy on intensive care unit admission and mortality among ' 'patients hospitalized for COVID-19: A pilot randomized clinical study', 'volume': '203', 'author': 'Entrenas Castillo', 'year': '2020', 'journal-title': 'J Steroid Biochem Mol Biol.'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib123', 'doi-asserted-by': 'crossref', 'first-page': '85', 'DOI': '10.1016/j.chest.2020.10.009', 'article-title': 'Use of Ivermectin Is Associated With Lower Mortality in Hospitalized ' 'Patients With Coronavirus Disease 2019: The Ivermectin in COVID ' 'Nineteen Study', 'volume': '159', 'author': 'Rajter', 'year': '2021', 'journal-title': 'Chest'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib124', 'doi-asserted-by': 'crossref', 'first-page': '462', 'DOI': '10.18433/jpps31457', 'article-title': 'Therapeutic potential of ivermectin as add on treatment in COVID 19: A ' 'systematic review and meta-analysis', 'volume': '23', 'author': 'Padhy', 'year': '2020', 'journal-title': 'J Pharm Pharm Sci'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib125', 'unstructured': 'Grant WB. Vitamin D acceptance delayed by big pharma following the ' 'Disinformation Playbook. Accessed March 22nd, 2022, ' 'http://orthomolecular.org/resources/omns/v14n22.shtml'}, { 'issue': '17', 'key': '10.1016/j.heliyon.2024.e34691_bib126', 'first-page': '15', 'article-title': 'Infections and autoimmunity-The immune system and vitamin D: A ' 'Systematic Review', 'author': 'Wimalawansa', 'year': '2023', 'journal-title': 'Nutrients'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib127', 'first-page': '1', 'article-title': 'Prophylactic use of vitamin D to maintain a robust immune system ' 'against infections like SARS-CoV-2', 'volume': '3', 'author': 'Wimalawansa', 'year': '2023', 'journal-title': 'Glob J Endocrinol Metab GJEM 000571'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib128', 'doi-asserted-by': 'crossref', 'first-page': '83', 'DOI': '10.1186/s12916-022-02290-8', 'article-title': 'A single-oral bolus of 100,000 IU of cholecalciferol at hospital ' 'admission did not improve outcomes in the COVID-19 disease: the ' 'COVID-VIT-D-a randomised multicentre international clinical trial', 'volume': '20', 'author': 'Cannata-Andia', 'year': '2022', 'journal-title': 'BMC Med'}, { 'issue': '11', 'key': '10.1016/j.heliyon.2024.e34691_bib129', 'doi-asserted-by': 'crossref', 'first-page': '1053', 'DOI': '10.1001/jama.2020.26848', 'article-title': 'Effect of a single high dose of vitamin D3 on hospital length of stay ' 'in patients Wpwith moderate to severe COVID-19: A randomized clinical ' 'trial', 'volume': '325', 'author': 'Murai', 'year': '2021', 'journal-title': 'JAMA'}, { 'issue': '10', 'key': '10.1016/j.heliyon.2024.e34691_bib130', 'doi-asserted-by': 'crossref', 'first-page': '5880', 'DOI': '10.1002/jmv.27133', 'article-title': 'In-hospital mortality in SARS-CoV-2 stratified by serum ' '25-hydroxy-vitamin D levels: A retrospective study', 'volume': '93', 'author': 'Al-Jarallah', 'year': '2021', 'journal-title': 'J Med Virol'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib131', 'doi-asserted-by': 'crossref', 'DOI': '10.1177/21501327211041206', 'article-title': 'Vitamin D Status and Severe COVID-19 Disease Outcomes in Hospitalized ' 'Patients', 'volume': '12', 'author': 'Pecina', 'year': '2021', 'journal-title': 'J Prim Care Community Health'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib132', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.nut.2020.111055', 'article-title': 'Vitamin D supplementation and outcomes in coronavirus disease 2019 ' '(COVID-19) patients from the outbreak area of Lombardy, Italy', 'volume': '82', 'author': 'Cereda', 'year': '2021', 'journal-title': 'Nutrition'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib133', 'doi-asserted-by': 'crossref', 'first-page': '42', 'DOI': '10.1136/bmjnph-2020-000151', 'article-title': 'No evidence that vitamin D is able to prevent or affect the severity of ' 'COVID-19 in individuals with European ancestry: a Mendelian ' 'randomisation study of open data', 'volume': '4', 'author': 'Amin', 'year': '2021', 'journal-title': 'BMJ Nutr Prev Health'}, { 'issue': '7', 'key': '10.1016/j.heliyon.2024.e34691_bib134', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/v13071292', 'article-title': 'Potential prophylactic treatments for COVID-19', 'volume': '13', 'author': 'Ben-Zuk', 'year': '2021', 'journal-title': 'Viruses'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib135', 'doi-asserted-by': 'crossref', 'first-page': '23', 'DOI': '10.1186/s12941-020-00368-w', 'article-title': 'Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19', 'volume': '19', 'author': 'Sharun', 'year': '2020', 'journal-title': 'Ann Clin Microbiol Antimicrob'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib136', 'first-page': '1', 'article-title': 'Fighting against COVID-19: Boosting the immunity with micronutrients, ' 'stress reduction, physical activity, and vitamin D', 'volume': '3', 'author': 'Wimalawansa', 'year': '2020', 'journal-title': 'Nutrition and Food Science Journal (Sci Literature)'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib137', 'doi-asserted-by': 'crossref', 'first-page': 'R27', 'DOI': '10.1530/EC-18-0432', 'article-title': 'Vitamin D testing and treatment: a narrative review of current evidence', 'volume': '8', 'author': 'Pilz', 'year': '2019', 'journal-title': 'Endocr Connect'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib138', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fimmu.2021.635371', 'article-title': 'Lack of effectiveness of repurposed drugs for COVID-19 treatment', 'volume': '12', 'author': 'Martinez', 'year': '2021', 'journal-title': 'Front Immunol'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib139', 'doi-asserted-by': 'crossref', 'first-page': '248', 'DOI': '10.1037/h0101793', 'article-title': 'Refuting spurious COVID-19 treatment claims reduces demand and ' 'misinformation sharing', 'volume': '10', 'author': 'MacFarlane', 'year': '2021', 'journal-title': 'J Appl Res Mem Cogn'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib140', 'doi-asserted-by': 'crossref', 'first-page': '595', 'DOI': '10.1097/PHH.0000000000001616', 'article-title': 'Disciplining physicians who spread medical misinformation', 'volume': '28', 'author': 'Yang', 'year': '2022', 'journal-title': 'J Public Health Manag Pract'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib141', 'article-title': 'Social media and COVID-19-perceptions and public deceptions of ' 'ivermectin, colchicine and hydroxychloroquine: Lessons for future ' 'pandemics', 'volume': '11', 'author': 'Schellack', 'year': '2022', 'journal-title': 'Antibiotics (Basel)'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib142', 'unstructured': 'FDA. Why you should not use ivermectin to treat or prevent COVID-19. ' 'FDA. 2023 March 12. ' 'https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib143', 'unstructured': 'Sun LH WL, GodfreyH. Doctors who put lives at risk with COVID ' 'misinformation rarely punished. Washington Post. 2023, Aug 10. ' 'https://www.washingtonpost.com/health/2023/07/26/covid-misinformation-doctor-discipline/'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib144', 'doi-asserted-by': 'crossref', 'first-page': '47', 'DOI': '10.1007/s40656-022-00532-9', 'article-title': 'The failure of drug repurposing for COVID-19 as an effect of excessive ' 'hypothesis testing and weak mechanistic evidence', 'volume': '44', 'author': 'Maziarz', 'year': '2022', 'journal-title': 'Hist Philos Life Sci.'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib145', 'article-title': 'Risks elaborated vs. risks downplayed: The effect of risk comparisons ' 'in mainstream mediaduring COVID-19 on risk perceptions and anxiety ' 'levels', 'volume': '6doi', 'author': 'Anderson', 'year': '2021', 'journal-title': 'Frontiers: Sci Environ Commun'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib146', 'article-title': 'The impact of disinformation on democratic processes and human rights ' 'in the world', 'author': 'Colomin', 'year': '2023', 'journal-title': 'European Parliment'}, { 'issue': '42', 'key': '10.1016/j.heliyon.2024.e34691_bib147', 'doi-asserted-by': 'crossref', 'first-page': '62887', 'DOI': '10.1007/s11356-022-21967-4', 'article-title': 'Pseudoscience and fraudulent products for COVID-19 management', 'volume': '29', 'author': 'Chavda', 'year': '2022', 'journal-title': 'Environmental science and pollution research international'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib148', 'article-title': 'FLCCC treatmemetn protocols', 'year': '2023', 'journal-title': 'FLCCC Alliance.'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib149', 'unstructured': 'Anonymus. At home treatment guide. World Council of Heatlh. 2022, August ' '7. ' 'https://worldcouncilforhealth.org/wp-content/uploads/2021/09/WCH-At-Home-Treatment-Guide_30-Sept-2021.pdf'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib150', 'unstructured': 'Kory P MJ. The war on ivermectin: The medicine that saved millions and ' 'could have ended the pandemic ' '[https://rumble.com/v41agxg-2023-12-14-mikki-willis-pierre-kory-the-war-on-ivermectin.html]. ' 'vol 1. ICAN Press; 2023.'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib151', 'unstructured': 'A. A. Why cheap, older drugs that might treat COVID never get out of the ' 'lab. ' 'https://kffhealthnews.org/news/article/repurposing-cheap-older-drugs-as-covid-treatment-camostat/'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib152', 'doi-asserted-by': 'crossref', 'first-page': '359', 'DOI': '10.1017/S0007114520002950', 'article-title': 'COVID-19 and misinformation: how an infodemic fuelled the prominence of ' 'vitamin D', 'volume': '125', 'author': 'Henrina', 'year': '2021', 'journal-title': 'Br J Nutr'}, { 'issue': '9', 'key': '10.1016/j.heliyon.2024.e34691_bib153', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/ofid/ofac469', 'article-title': 'COVID-19 Vaccine Effectiveness Against Progression to In-Hospital ' 'Mortality in Zambia, 2021-2022', 'volume': '9', 'author': 'Chanda', 'year': '2022', 'journal-title': 'Open Forum Infect Dis'}, { 'issue': '12', 'key': '10.1016/j.heliyon.2024.e34691_bib154', 'article-title': 'Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired ' 'Immunity: A Comparison of Three COVID-19 Vaccines', 'volume': '10', 'author': 'Samanovic', 'year': '2022', 'journal-title': 'Vaccines (Basel)'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib155', 'article-title': 'Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA ' 'Vaccine or SARS-CoV-2 Infection', 'volume': '10', 'author': 'Israel', 'year': '2021', 'journal-title': 'Vaccines (Basel)'}, { 'issue': '12', 'key': '10.1016/j.heliyon.2024.e34691_bib156', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/molecules27123851', 'article-title': 'Structural Dynamics of the SARS-CoV-2 Spike Protein: A 2-Year ' 'Retrospective Analysis of SARS-CoV-2 Variants (from Alpha to Omicron) ' 'Reveals an Early Divergence between Conserved and Variable Epitopes', 'volume': '27', 'author': 'Guerin', 'year': '2022', 'journal-title': 'Molecules'}, { 'issue': '10', 'key': '10.1016/j.heliyon.2024.e34691_bib157', 'doi-asserted-by': 'crossref', 'first-page': '5056', 'DOI': '10.1002/jmv.27954', 'article-title': 'Antibody titers after a third dose of the SARS-CoV-2 BNT162b2 vaccine ' 'in immunocompromised adults in Greece: Is a fourth dose necessary?', 'volume': '94', 'author': 'Kontopoulou', 'year': '2022', 'journal-title': 'J Med Virol'}, { 'issue': '46', 'key': '10.1016/j.heliyon.2024.e34691_bib158', 'doi-asserted-by': 'crossref', 'first-page': '6664', 'DOI': '10.1016/j.vaccine.2022.09.080', 'article-title': 'COVID-19 outbreak in an elderly care home: Very low vaccine ' 'effectiveness and late impact of booster vaccination campaign', 'volume': '40', 'author': 'van Ewijk', 'year': '2022', 'journal-title': 'Vaccine'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib159', 'article-title': 'Herd immunity to fight against COVID-19: A narrative review', 'volume': '15', 'author': 'Suryawanshi', 'year': '2023', 'journal-title': 'Cureus'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib160', 'first-page': '1', 'article-title': 'Association of sex, sge, and comorbidities with mortality in COVID-19 ' 'Patients: A systematic review and meta-analysis', 'author': 'Biswas', 'year': '2020', 'journal-title': 'Intervirology'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib161', 'first-page': '1', 'article-title': 'Maintaining optimum health requires longer-term stable vitamin D ' 'concentrations', 'volume': '3', 'author': 'Wimalawansa', 'year': '2020', 'journal-title': 'Int J Regenr Med'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib162', 'first-page': '1', 'article-title': 'Effective and practical ways to overcome vitamin D deficiency', 'volume': '8', 'author': 'Wimalawansa', 'year': '2021', 'journal-title': 'J Family Med Community Health'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib163', 'doi-asserted-by': 'crossref', 'first-page': '663', 'DOI': '10.1093/infdis/jiac453', 'article-title': 'Use of Whole-Genome Sequencing to Estimate the Contribution of Immune ' 'Evasion and Waning Immunity on Decreasing COVID-19 Vaccine ' 'Effectiveness', 'volume': '227', 'author': 'Lind', 'year': '2023', 'journal-title': 'J Infect Dis'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib164', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/S2666-5247(22)00335-4', 'article-title': 'Omicron sublineage recombinant XBB evades neutralising antibodies in ' 'recipients of BNT162b2 or CoronaVac vaccines', 'volume': '4', 'author': 'Zhang', 'year': '2023', 'journal-title': 'Lancet Microbe'}, { 'issue': '8', 'key': '10.1016/j.heliyon.2024.e34691_bib165', 'doi-asserted-by': 'crossref', 'first-page': '763', 'DOI': '10.1016/j.healun.2021.04.018', 'article-title': 'COVID-19 vaccination immune paresis in heart and lung transplantation', 'volume': '40', 'author': 'Aslam', 'year': '2021', 'journal-title': 'J Heart Lung Transplant'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib166', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/ofid/ofad209', 'article-title': 'Effectiveness of the coronavirus disease 2019 bivalent vaccine', 'volume': '10', 'author': 'Shrestha', 'year': '2023', 'journal-title': 'Open Forum Infect Dis'}, { 'issue': '12', 'key': '10.1016/j.heliyon.2024.e34691_bib167', 'doi-asserted-by': 'crossref', 'first-page': '2169', 'DOI': '10.1093/cid/ciac327', 'article-title': 'Coronavirus Disease 2019 Vaccine Boosting in Previously Infected or ' 'Vaccinated Individuals', 'volume': '75', 'author': 'Shrestha', 'year': '2022', 'journal-title': 'Clin Infect Dis'}, { 'issue': '12', 'key': '10.1016/j.heliyon.2024.e34691_bib168', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/v14122688', 'article-title': 'Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness ' 'during the Omicron Transmission Period in Healthcare Workers of Trieste ' 'and Gorizia (Northeast Italy), 1 December 2021-31 May 2022', 'volume': '14', 'author': 'Cegolon', 'year': '2022', 'journal-title': 'Viruses'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib169', 'article-title': 'Breakthrough SARS-CoV-2 infections among patients with cancer following ' 'two and three doses of COVID-19 mRNA vaccines: a retrospective ' 'observational study from the COVID-19 and Cancer Consortium', 'volume': '19', 'author': 'Choueiri', 'year': '2023', 'journal-title': 'Lancet Reg Health Am'}, { 'issue': '7923', 'key': '10.1016/j.heliyon.2024.e34691_bib170', 'doi-asserted-by': 'crossref', 'first-page': '603', 'DOI': '10.1038/s41586-022-05053-w', 'article-title': 'Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and ' 'BA.5', 'volume': '608', 'author': 'Wang', 'year': '2022', 'journal-title': 'Nature'}, { 'issue': '10343', 'key': '10.1016/j.heliyon.2024.e34691_bib171', 'doi-asserted-by': 'crossref', 'first-page': '2263', 'DOI': '10.1016/S0140-6736(22)00941-2', 'article-title': 'Risk of long COVID associated with delta versus omicron variants of ' 'SARS-CoV-2', 'volume': '399', 'author': 'Antonelli', 'year': '2022', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib172', 'article-title': 'Clinical severity according to the primary infection variant in ' 'patients with suspected SARS-CoV-2 reinfection in Korea', 'volume': '45', 'author': 'Hwang', 'year': '2023', 'journal-title': 'Epidemiol Health'}, { 'issue': '9', 'key': '10.1016/j.heliyon.2024.e34691_bib173', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.ppat.1010876', 'article-title': 'Shedding of infectious SARS-CoV-2 despite vaccination', 'volume': '18', 'author': 'Riemersma', 'year': '2022', 'journal-title': 'PLoS Pathog'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib174', 'doi-asserted-by': 'crossref', 'first-page': '735', 'DOI': '10.1186/s12879-020-05469-7', 'article-title': 'The potential impact of a recent measles epidemic on COVID-19 in Samoa', 'volume': '20', 'author': 'MacIntyre', 'year': '2020', 'journal-title': 'BMC Infect Dis'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib175', 'doi-asserted-by': 'crossref', 'first-page': '567', 'DOI': '10.1056/NEJMc2213907', 'article-title': 'Antibody Response to Omicron BA.4-BA.5 Bivalent Booster', 'volume': '388', 'author': 'Wang', 'year': '2023', 'journal-title': 'N Engl J Med'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib176', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/ofid/ofac698', 'article-title': 'Absolute and Relative Vaccine Effectiveness of Primary and Booster ' 'Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against ' 'COVID-19 Hospitalizations in the United States, December 2021-April ' '2022', 'volume': '10', 'author': 'Lewis', 'year': '2023', 'journal-title': 'Open Forum Infect Dis'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib177', 'article-title': 'Serial negative response after standard and third (Booster) dose of ' 'COVID-19 inactivated vaccine is associated with low vitamin D levels in ' 'patients with solid cancers', 'volume': '9', 'author': 'Ma', 'year': '2022', 'journal-title': 'Front Med (Lausanne)'}, { 'issue': '12', 'key': '10.1016/j.heliyon.2024.e34691_bib178', 'article-title': 'Safety of Four COVID-19 Vaccines across Primary Doses 1, 2, 3 and ' 'Booster: A Prospective Cohort Study of Australian Community Pharmacy ' 'Vaccinations', 'volume': '10', 'author': 'Salter', 'year': '2022', 'journal-title': 'Vaccines (Basel)'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib179', 'unstructured': 'CDC U. Effectiveness of bivalent mRNA vaccines in preventing symptomatic ' 'SARS-CoV-2 infection—increasing community access to testing program, ' 'United States: CDC-MMWR Report, Sept.–Nov. 2022. CDC. Accessed January ' '6, 2023. ' 'https://www.cdc.gov/mmwr/volumes/71/wr/mm7148e1.htm?s_cid=mm7148e1_w#T2_down'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib180', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pone.0259610', 'article-title': 'Profiling RT-LAMP tolerance of sequence variation for SARS-CoV-2 RNA ' 'detection', 'volume': '17', 'author': 'Tamanaha', 'year': '2022', 'journal-title': 'PLoS One'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib181', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fmicb.2022.1027271', 'article-title': 'Investigating SARS-CoV-2 breakthrough infections per variant and ' 'vaccine type', 'volume': '13', 'author': 'Dingemans', 'year': '2022', 'journal-title': 'Front Microbiol'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib182', 'doi-asserted-by': 'crossref', 'first-page': '30', 'DOI': '10.1016/S1473-3099(22)00816-7', 'article-title': 'Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB', 'volume': '23', 'author': 'Uraki', 'year': '2023', 'journal-title': 'Lancet Infect Dis'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib183', 'doi-asserted-by': 'crossref', 'first-page': 'e662', 'DOI': '10.1093/cid/ciac022', 'article-title': 'Necessity of coronavirus disease 2019 (COVID-19) vaccination in persons ' 'who have already had COVID-19', 'volume': '75', 'author': 'Shrestha', 'year': '2022', 'journal-title': 'Clin Infect Dis'}, { 'issue': '10', 'key': '10.1016/j.heliyon.2024.e34691_bib184', 'doi-asserted-by': 'crossref', 'first-page': '1067', 'DOI': '10.1111/crj.13694', 'article-title': 'Interactive effect of booster vaccination and vitamin D status on ' 'antibody production of Omicron variant-infected adults: A real-world ' 'cohort study', 'volume': '17', 'author': 'Peng', 'year': '2023', 'journal-title': 'Clin Respir J'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib185', 'doi-asserted-by': 'crossref', 'first-page': '59', 'DOI': '10.1016/j.vaccine.2020.10.048', 'article-title': 'Evaluating association of vaccine response to low serum zinc and ' 'vitamin D levels in children of a birth cohort study in Dhaka', 'volume': '39', 'author': 'Das', 'year': '2021', 'journal-title': 'Vaccine'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib186', 'doi-asserted-by': 'crossref', 'first-page': '56', 'DOI': '10.1016/j.jaci.2022.05.001', 'article-title': 'SARS-CoV-2 vaccination in the immunocompromised host', 'volume': '150', 'author': 'Connolly', 'year': '2022', 'journal-title': 'J Allergy Clin Immunol'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib187', 'first-page': '432', 'article-title': 'Global epidemic of coronavirus—COVID-19: What can we do to minimize ' 'risks?', 'volume': '7', 'author': 'Wimalawansa', 'year': '2020', 'journal-title': 'European J Biomed & Pharma Sci'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib188', 'doi-asserted-by': 'crossref', 'first-page': '491', 'DOI': '10.1016/j.actbio.2022.08.006', 'article-title': 'Single-injection COVID-19 subunit vaccine elicits potent immune ' 'responses', 'volume': '151', 'author': 'Zhou', 'year': '2022', 'journal-title': 'Acta Biomater'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib189', 'article-title': 'Intraduodenal Delivery of Exosome-Loaded SARS-CoV-2 RBD mRNA Induces a ' 'Neutralizing Antibody Response in Mice', 'volume': '11', 'author': 'Zhang', 'year': '2023', 'journal-title': 'Vaccines (Basel)'}, { 'issue': '27', 'key': '10.1016/j.heliyon.2024.e34691_bib190', 'doi-asserted-by': 'crossref', 'first-page': '2603', 'DOI': '10.1056/NEJMoa2034577', 'article-title': 'Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine', 'volume': '383', 'author': 'Polack', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib191', 'doi-asserted-by': 'crossref', 'first-page': '403', 'DOI': '10.1056/NEJMoa2035389', 'article-title': 'Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine', 'volume': '384', 'author': 'Baden', 'year': '2021', 'journal-title': 'N Engl J Med'}, { 'issue': '13', 'key': '10.1016/j.heliyon.2024.e34691_bib192', 'doi-asserted-by': 'crossref', 'first-page': '495', 'DOI': '10.15585/mmwr.mm7013e3', 'volume': '70', 'author': 'Thompson', 'year': '2021', 'journal-title': 'MMWR Morbidity and mortality weekly report'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib193', 'unstructured': 'Anonymus. Coronavirus disease (COVID-19): Herd immunity, lockdowns and ' 'COVID-19. WHO-Questins and answers. Accessed 20 February 2024, ' 'https://www.who.int/news-room/questions-and-answers/item/herd-immunity-lockdowns-and-covid-19'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib194', 'doi-asserted-by': 'crossref', 'first-page': '202', 'DOI': '10.1007/s13668-020-00330-4', 'article-title': 'Can Vitamins, as Epigenetic Modifiers, Enhance Immunity in COVID-19 ' 'Patients with Non-communicable Disease?', 'volume': '9', 'author': 'Singh', 'year': '2020', 'journal-title': 'Curr Nutr Rep'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib195', 'unstructured': 'Weixel N. CDC: More vaccinated adults hospitalized with omicron, but ' 'fewer admitted to ICU. ' 'https://thehill.com/policy/healthcare/592847-cdc-more-vaccinated-adults-hospitalized-with-omicron-but-fewer-admitted-to/'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib196', 'article-title': 'IgG4 antibodies induced by repeated vaccination may generate immune ' 'tolerance to the SARS-CoV-2 Spike protein', 'volume': '11', 'author': 'Uversky', 'year': '2023', 'journal-title': 'Vaccines (Basel)'}, { 'issue': '8', 'key': '10.1016/j.heliyon.2024.e34691_bib197', 'article-title': "COVID-19 excess deaths in Peru's 25 States in 2020: Nationwide trends, " 'confounding factors, and correlations with the extent of ivermectin ' 'treatment by State', 'volume': '15', 'author': 'Chamie', 'year': '2023', 'journal-title': 'Cureus'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib198', 'doi-asserted-by': 'crossref', 'first-page': '334', 'DOI': '10.1186/s12887-021-02803-z', 'article-title': 'Concentration levels of serum 25-Hydroxyvitamin-D and vitamin D ' 'deficiency among children and adolescents of India: a descriptive ' 'cross-sectional study', 'volume': '21', 'author': 'Mustafa', 'year': '2021', 'journal-title': 'BMC Pediatr'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib199', 'doi-asserted-by': 'crossref', 'DOI': '10.1080/21645515.2022.2163813', 'article-title': 'Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants ' 'during two outbreaks from March to May 2022 in Quzhou, China', 'volume': '19', 'author': 'Yin', 'year': '2023', 'journal-title': 'Hum Vaccin Immunother'}, { 'issue': '8', 'key': '10.1016/j.heliyon.2024.e34691_bib200', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/microorganisms11082073', 'article-title': 'Early fluvoxaminereduces the risk for clinical deterioration in ' 'symptomatic outpatients with COVID-19: A real-world, retrospective, ' 'before-after analysis', 'volume': '11', 'author': 'Tsiakalos', 'year': '2023', 'journal-title': 'Microorganisms'}, { 'issue': '22', 'key': '10.1016/j.heliyon.2024.e34691_bib201', 'doi-asserted-by': 'crossref', 'first-page': '2292', 'DOI': '10.1001/jama.2020.22760', 'article-title': 'Fluvoxamine vs placebo and clinical deterioration in outpatients with ' 'symptomatic COVID-19: A randomized clinical trial', 'volume': '324', 'author': 'Lenze', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib202', 'article-title': 'Elderberries-A source of bioactive compounds with antiviral action', 'volume': '11', 'author': 'Mocanu', 'year': '2022', 'journal-title': 'Plants (Basel)'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib203', 'doi-asserted-by': 'crossref', 'first-page': '2616', 'DOI': '10.1002/ptr.7004', 'article-title': 'Oral nano-curcumin formulation efficacy in management of mild to ' 'moderate hospitalized coronavirus disease-19 patients: An open label ' 'nonrandomized clinical trial', 'volume': '35', 'author': 'Saber-Moghaddam', 'year': '2021', 'journal-title': 'Phytother Res'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib204', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ctim.2021.102769', 'article-title': 'Nigella sativa for the treatment of COVID-19: An open-label randomized ' 'controlled clinical trial', 'volume': '61', 'author': 'Koshak', 'year': '2021', 'journal-title': 'Complement Ther Med'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib205', 'doi-asserted-by': 'crossref', 'first-page': '2102', 'DOI': '10.1002/jmv.27595', 'article-title': 'Efficacy of melatonin in the treatment of patients with COVID-19: A ' 'systematic review and meta-analysis of randomized controlled trials', 'volume': '94', 'author': 'Lan', 'year': '2022', 'journal-title': 'J Med Virol'}, { 'issue': '20', 'key': '10.1016/j.heliyon.2024.e34691_bib206', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/jcm11206138', 'article-title': 'Early outpatient treatment of COVID-19: A retrospective analysis of 392 ' 'cases in Italy', 'volume': '11', 'author': 'Cosentino', 'year': '2022', 'journal-title': 'J Clin Med'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib207', 'doi-asserted-by': 'crossref', 'first-page': '622', 'DOI': '10.1016/j.jinf.2023.02.029', 'article-title': 'Molnupiravir and nirmatrelvir-ritonavir reduce mortality risk during ' 'post-acute COVID-19 phase', 'volume': '86', 'author': 'Wan', 'year': '2023', 'journal-title': 'J Infect'}, { 'issue': '12', 'key': '10.1016/j.heliyon.2024.e34691_bib208', 'doi-asserted-by': 'crossref', 'first-page': '1404', 'DOI': '10.1001/jamainternmed.2023.5099', 'article-title': 'Nirmatrelvir and Molnupiravir and post-COVID-19 condition in older ' 'patients', 'volume': '183', 'author': 'Fung', 'year': '2023', 'journal-title': 'JAMA Intern Med'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib209', 'doi-asserted-by': 'crossref', 'first-page': 'e342', 'DOI': '10.1093/cid/ciac443', 'article-title': 'Effectiveness of Paxlovid in reducingsevere coronavirus gisease 2019 ' 'and mortality in high-risk patients', 'volume': '76', 'author': 'Najjar-Debbiny', 'year': '2023', 'journal-title': 'Clin Infect Dis'}, { 'issue': '11', 'key': '10.1016/j.heliyon.2024.e34691_bib210', 'doi-asserted-by': 'crossref', 'first-page': '1486', 'DOI': '10.7326/M23-1394', 'article-title': 'Effectiveness of Nirmatrelvir-Ritonavir against the development of ' 'post-COVID-19 conditions among U.S. Veterans : A target trial emulation', 'volume': '176', 'author': 'Ioannou', 'year': '2023', 'journal-title': 'Ann Intern Med'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib211', 'doi-asserted-by': 'crossref', 'first-page': '209', 'DOI': '10.1016/S1473-3099(21)00485-0', 'article-title': 'Remdesivir plus standard of care versus standard of care alone for the ' 'treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a ' 'phase 3, randomised, controlled, open-label trial', 'volume': '22', 'author': 'Ader', 'year': '2022', 'journal-title': 'Lancet Infect Dis'}, { 'issue': '9', 'key': '10.1016/j.heliyon.2024.e34691_bib212', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pone.0290964', 'article-title': 'Characteristics and outcomes of patients with severe COVID-19 in ' 'Indonesia: Lessons from the first wave', 'volume': '18', 'author': 'Burhan', 'year': '2023', 'journal-title': 'PLoS One'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib213', 'article-title': 'Is ivermectin effective in treating COVID-19?', 'volume': '13', 'author': 'Yang', 'year': '2022', 'journal-title': 'Frontiers in pharmacology'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib214', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jamanetworkopen.2022.3079', 'article-title': 'Comparison of trials using ivermectin for COVID-19 between regions with ' 'high and low prevalence of strongyloidiasis: A meta-analysis', 'volume': '5', 'author': 'Bitterman', 'year': '2022', 'journal-title': 'JAMA Netw Open'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib215', 'doi-asserted-by': 'crossref', 'first-page': '343', 'DOI': '10.18433/jpps32105', 'article-title': 'Evaluation of ivermectin as a potential treatment for mild to moderate ' 'COVID-19: A double-blind randomized placebo Controlled ttrial in ' 'eastern India', 'volume': '24', 'author': 'Ravikirti', 'year': '2021', 'journal-title': 'J Pharm Pharm Sci'}, { 'issue': '5', 'key': '10.1016/j.heliyon.2024.e34691_bib216', 'doi-asserted-by': 'crossref', 'DOI': '10.1177/03000605211013550', 'article-title': 'Ivermectin in combination with doxycycline for treating COVID-19 ' 'symptoms: a randomized trial', 'volume': '49', 'author': 'Mahmud', 'year': '2021', 'journal-title': 'J Int Med Res'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib217', 'doi-asserted-by': 'crossref', 'first-page': '2179', 'DOI': '10.1007/s11357-023-00756-y', 'article-title': 'Results of a systematic review and meta-analysis of early studies on ' 'ivermectin in SARS-CoV-2 infection', 'volume': '45', 'author': 'Rago', 'year': '2023', 'journal-title': 'Geroscience'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib218', 'doi-asserted-by': 'crossref', 'first-page': 'e434', 'DOI': '10.1097/MJT.0000000000001402', 'article-title': 'Ivermectin for prevention and treatment of COVID-19 infection: A ' 'systematic review, meta-analysis, and trial sequential analysis to ' 'inform clinical guidelines', 'volume': '28', 'author': 'Bryant', 'year': '2021', 'journal-title': 'Am J Ther'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib219', 'doi-asserted-by': 'crossref', 'first-page': '827', 'DOI': '10.1093/jac/dkz524', 'article-title': 'Safety of high-dose ivermectin: a systematic review and meta-analysis', 'volume': '75', 'author': 'Navarro', 'year': '2020', 'journal-title': 'J Antimicrob Chemother'}, { 'issue': '10', 'key': '10.1016/j.heliyon.2024.e34691_bib220', 'doi-asserted-by': 'crossref', 'first-page': '1122', 'DOI': '10.1177/009127002237994', 'article-title': 'Safety, tolerability, and pharmacokinetics of escalating high doses of ' 'ivermectin in healthy adult subjects', 'volume': '42', 'author': 'Guzzo', 'year': '2002', 'journal-title': 'J Clin Pharmacol'}, { 'issue': '2', 'key': '10.1016/j.heliyon.2024.e34691_bib221', 'doi-asserted-by': 'crossref', 'DOI': '10.5812/jjhs-146703', 'article-title': 'Ivermectin as a potential addition to the limited anti-COVID-19 ' 'arsenal: A double-blinded clinical trial', 'volume': '16', 'author': 'Varnaseri', 'year': '2024', 'journal-title': 'Jundishapur J Health Sci'}, { 'issue': '4', 'key': '10.1016/j.heliyon.2024.e34691_bib222', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.jinf.2024.106130', 'article-title': 'Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An ' 'open, randomised, controlled, adaptive platform trial of short- and ' 'longer-term outcomes', 'volume': '88', 'author': 'Hayward', 'year': '2024', 'journal-title': 'J Infect'}, { 'issue': '18', 'key': '10.1016/j.heliyon.2024.e34691_bib223', 'doi-asserted-by': 'crossref', 'first-page': '1721', 'DOI': '10.1056/NEJMoa2115869', 'article-title': 'Effect of early treatment with Ivermectin among patients with Covid-19', 'volume': '386', 'author': 'Reis', 'year': '2022', 'journal-title': 'N Engl J Med'}, { 'issue': '16', 'key': '10.1016/j.heliyon.2024.e34691_bib224', 'doi-asserted-by': 'crossref', 'first-page': '1595', 'DOI': '10.1001/jama.2022.18590', 'article-title': 'Effect of ivermectin vs placebo on time to sustained recovery in ' 'outpatients with mild to moderate COVID-19: A randomized clinical trial', 'volume': '328', 'author': 'Naggie', 'year': '2022', 'journal-title': 'JAMA'}, { 'issue': '7', 'key': '10.1016/j.heliyon.2024.e34691_bib225', 'doi-asserted-by': 'crossref', 'first-page': '599', 'DOI': '10.1056/NEJMoa2201662', 'article-title': 'Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19', 'volume': '387', 'author': 'Bramante', 'year': '2022', 'journal-title': 'N Engl J Med'}, { 'issue': '10', 'key': '10.1016/j.heliyon.2024.e34691_bib226', 'doi-asserted-by': 'crossref', 'first-page': '1119', 'DOI': '10.1016/S1473-3099(23)00299-2', 'article-title': 'Outpatient treatment of COVID-19 and incidence of post-COVID-19 ' 'condition over 10 months (COVID-OUT): a multicentre, randomised, ' 'quadruple-blind, parallel-group, phase 3 trial', 'volume': '23', 'author': 'Bramante', 'year': '2023', 'journal-title': 'Lancet Infect Dis'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib227', 'article-title': 'Ivermectin for preventing and treating COVID-19', 'volume': '6', 'author': 'Popp', 'year': '2022', 'journal-title': 'Cochrane Database Syst Rev'}, { 'issue': '1', 'key': '10.1016/j.heliyon.2024.e34691_bib228', 'doi-asserted-by': 'crossref', 'first-page': '639', 'DOI': '10.1186/s12879-022-07589-8', 'article-title': 'Systematic review and meta-analysis of ivermectin for treatment of ' 'COVID-19: evidence beyond the hype', 'volume': '22', 'author': 'Marcolino', 'year': '2022', 'journal-title': 'BMC Infect Dis'}, { 'issue': '11', 'key': '10.1016/j.heliyon.2024.e34691_bib229', 'doi-asserted-by': 'crossref', 'first-page': '888', 'DOI': '10.1001/jama.2023.1650', 'article-title': 'Effect of higher-dose ivermectin for 6 Days vs placebo on time to ' 'sustained recovery in outpatients with COVID-19: A randomized clinical ' 'trial', 'volume': '329', 'author': 'Naggie', 'year': '2023', 'journal-title': 'JAMA'}, { 'issue': '14', 'key': '10.1016/j.heliyon.2024.e34691_bib230', 'doi-asserted-by': 'crossref', 'first-page': '1426', 'DOI': '10.1001/jama.2021.3071', 'article-title': 'Effect of ivermectin on time to resolution of symptoms Among adults ' 'with mild COVID-19: A randomized clinical trial', 'volume': '325', 'author': 'Lopez-Medina', 'year': '2021', 'journal-title': 'JAMA'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib231', 'doi-asserted-by': 'crossref', 'first-page': '1022', 'DOI': '10.1093/cid/ciab591', 'article-title': 'Ivermectin for the treatment of coronavirus disease 2019: A systematic ' 'review and Meta-analysis of randomized controlled trials', 'volume': '74', 'author': 'Roman', 'year': '2022', 'journal-title': 'Clin Infect Dis'}, { 'issue': '3', 'key': '10.1016/j.heliyon.2024.e34691_bib232', 'doi-asserted-by': 'crossref', 'first-page': '309', 'DOI': '10.1177/10600280211028242', 'article-title': 'Interventions in an ambulatory setting to prevent progression to severe ' 'disease in patients with COVID-19: A systematic review', 'volume': '56', 'author': 'E', 'year': '2022', 'journal-title': 'Ann Pharmacother'}, { 'issue': '12', 'key': '10.1016/j.heliyon.2024.e34691_bib233', 'article-title': 'Effectiveness of COVID-19 Vaccines over 13 Months Covering the Period ' 'of the Emergence of the Omicron Variant in the Swedish Population', 'volume': '10', 'author': 'Xu', 'year': '2022', 'journal-title': 'Vaccines (Basel)'}, { 'issue': '6', 'key': '10.1016/j.heliyon.2024.e34691_bib234', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pone.0065835', 'article-title': 'Vitamin D and respiratory tract iInfections: A systematic review and ' 'meta-analysis of randomized controlled trials', 'volume': '8', 'author': 'Bergman', 'year': '2013', 'journal-title': 'PLoS One'}, { 'issue': '11', 'key': '10.1016/j.heliyon.2024.e34691_bib235', 'doi-asserted-by': 'crossref', 'first-page': '524', 'DOI': '10.1007/s00011-008-8007-8', 'article-title': 'Ivermectin inhibits LPS-induced production of inflammatory cytokines ' 'and improves LPS-induced survival in mice', 'volume': '57', 'author': 'Zhang', 'year': '2008', 'journal-title': 'Inflamm Res'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib236', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.1186/1743-422X-2-69', 'article-title': 'Chloroquine is a potent inhibitor of SARS coronavirus infection and ' 'spread', 'volume': '2', 'author': 'Vincent', 'year': '2005', 'journal-title': 'Virol J'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib237', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fnut.2023.1132528', 'article-title': 'The effects of vitamin D on all-cause mortality in different diseases: ' 'an evidence-map and umbrella review of 116 randomized controlled trials', 'volume': '10', 'author': 'Cao', 'year': '2023', 'journal-title': 'Front Nutr'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib238', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.antiviral.2020.104787', 'article-title': 'The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 ' 'in vitro', 'volume': '178', 'author': 'Caly', 'year': '2020', 'journal-title': 'Antiviral Res'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib239', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.nmni.2023.101172', 'article-title': 'Efficacy and safety of in-hospital treatment of Covid-19 infection with ' 'low-dose hydroxychloroquine and azithromycin in hospitalized patients: ' 'A retrospective controlled cohort study', 'volume': '55', 'author': 'Meeus', 'year': '2023', 'journal-title': 'New Microbes New Infect'}, { 'key': '10.1016/j.heliyon.2024.e34691_bib240', 'unstructured': 'Anonymus. COVID-19 Treatment Guidelines-Vitamin D. NIH. Accessed March ' '17, 2024, ' 'https://www.covid19treatmentguidelines.nih.gov/therapies/supplements/vitamin-d/'}, { 'issue': '12', 'key': '10.1016/j.heliyon.2024.e34691_bib241', 'doi-asserted-by': 'crossref', 'first-page': '1151', 'DOI': '10.1056/NEJMc2301323', 'article-title': 'Bivalent Covid-19 Vaccines', 'volume': '388', 'author': 'Marks', 'year': '2023', 'journal-title': 'N Engl J Med'}], 'container-title': 'Heliyon', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S2405844024107220?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S2405844024107220?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2024, 7, 18]], 'date-time': '2024-07-18T01:36:34Z', 'timestamp': 1721266594000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S2405844024107220'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 7]]}, 'references-count': 241, 'alternative-id': ['S2405844024107220'], 'URL': 'http://dx.doi.org/10.1016/j.heliyon.2024.e34691', 'relation': {}, 'ISSN': ['2405-8440'], 'subject': [], 'container-title-short': 'Heliyon', 'published': {'date-parts': [[2024, 7]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Unlocking Insights: Navigating COVID-19 Challenges and Emulating Future ' 'Pandemic Resilience Strategies with Strengthening Natural Immunity', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Heliyon', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.heliyon.2024.e34691', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, {'value': '© 2024 Published by Elsevier Ltd.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': 'e34691'}